Skip to content
10-Q

Quarterly Report

AXCELLA HEALTH INC.

0001633070-23-000011

← back to feed
Filed
May 4, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Apr 28, 2023 73.69M sh
Shares Diluted Q1 2023 · Mar 31, 2023 73.67M sh
Shares Diluted Q1 2023 · Mar 31, 2022 41.43M sh
Capex Q1 2023 · Mar 31, 2023 $0
Capex Q1 2023 · Mar 31, 2022 $164K
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$5.11M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$16.86M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $12.54M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $17.15M
Stockholders Equity Q1 2023 · Mar 31, 2023 $727K
Stockholders Equity Q1 2023 · Dec 31, 2022 $4.16M
Stockholders Equity Q1 2023 · Mar 31, 2022 $29.89M
Stockholders Equity Q1 2023 · Dec 31, 2021 $22.01M
Current Liabilities Q1 2023 · Mar 31, 2023 $11.89M
Current Liabilities Q1 2023 · Dec 31, 2022 $14.15M
Total Liabilities Q1 2023 · Mar 31, 2023 $12.04M
Total Liabilities Q1 2023 · Dec 31, 2022 $14.76M
Current Assets Q1 2023 · Mar 31, 2023 $12.74M
Current Assets Q1 2023 · Dec 31, 2022 $18.02M
Total Assets Q1 2023 · Mar 31, 2023 $12.77M
Total Assets Q1 2023 · Dec 31, 2022 $18.93M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.05
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.46
Eps Basic Q1 2023 · Mar 31, 2023 −$0.05
Eps Basic Q1 2023 · Mar 31, 2022 −$0.46
Sga Expense Q1 2023 · Mar 31, 2023 $2.75M
Sga Expense Q1 2023 · Mar 31, 2022 $4.79M
Rd Expense Q1 2023 · Mar 31, 2023 $1.43M
Rd Expense Q1 2023 · Mar 31, 2022 $13.54M
Net Income Q1 2023 · Mar 31, 2023 −$3.98M
Net Income Q1 2023 · Mar 31, 2022 −$19.04M
Operating Income Q1 2023 · Mar 31, 2023 −$4.18M
Operating Income Q1 2023 · Mar 31, 2022 −$18.33M